Stock UniverseDerived research view · source repositories remain read-only

Neurogene Inc. (NGNE)

Therapeutics / Biopharma · Healthcare / Biotechnology
Score Band
Speculative
Selection Score
29.93
Global Rank
2023
Market Cap
363.86M
Latest Close
26.49
RS Composite
6.28% · G#941

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
-18.06%
3M
19.49%
6M
31.66%
1Y
22.24%
3Y
65.56%
5Y
-86.79%
10Y
-83.91%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 66.26K · 30-day average: 135.82K · Max drawdown over stored range: -98.14%

Research Snapshot

Relative Strength vs SPX

RS Composite6.28%
20D RS-15.89%
60D RS6.05%
120D RS17.61%
Global RS Rank941 · 71.95% percentile
Watch+Speculative RS Rank588 · 71.96% percentile
Group ScopeWatch+Speculative
Primary RS Rank106 · 76.86% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank309 / 701
Primary Percentile56.06
Score Notesmarket-cap support, industry-tailwind, small-cap penalty

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

No processed TTM rows for NGNE.

TTM Valuation

No SEC TTM valuation available.

Financial Statement Metrics

MetricFY 2021FY 2022FY 2023FY 2024FY 2025
Revenue0000.925
Revenue Growth (YoY)
Gross Profit-42.264-47.505-44.394-59.892-74.891
Operating Income-50.534-56.517-55.583-82.505-103.208
Free Cash Flow-64.769-55.054-51.743-71.411-78.356
Free Cash Flow Per Share-15.986-139.542-11.111-4.065-3.674
EPS (Diluted) GAAP-12.468561-139.8843692.93-4.28-4.236603
EPS Growth
EPS Non-GAAP
Gross Margin100%
Operating Margin2400%2400%2400%-8919.459%
Profit Margin2400%2400%2400%-8123.676%
Free Cash Flow Margin2400%2400%2400%-7720.108%
Shares Outstanding (Diluted)4.05150.39454.656917.567121.3263
Shares Change (YoY)2400%-90.262%1080.369%277.223%21.399%

SEC Quarterly Fundamentals

No processed quarterly rows for NGNE.